Apollomics (APLM) Non-Current Assets (2021 - 2025)
Apollomics (APLM) posted quarterly Non-Current Assets of $663000.0 for Q4 2025, down 76.58% year-on-year from $2.8 million in Q4 2024, and down 33.03% on a QoQ basis from $990000.0 in Q2 2025.
Apollomics (APLM) Non-Current Assets (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Non-Current Assets for 5 consecutive years, with $663000.0 the latest figure, recorded in Q4 2025.
- Quarterly Non-Current Assets fell 76.58% year-over-year to $663000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $663000.0 (down 76.58% YoY) and the FY2025 annual result came in at $663000.0, down 76.58% from the prior year.
- Non-Current Assets slipped to $663000.0 in Q4 2025 per APLM's latest filing, from $990000.0 in the prior quarter.
- Over the last five years, Non-Current Assets for APLM reached as high as $20.7 million in Q4 2022 and fell as low as -$99.4 million in Q4 2021.
- A 5-year average of -$4.6 million and a median of $4.5 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets jumped 120.82% — and 2025, when it tumbled 83.93%.
- Year by year, Non-Current Assets stood at -$99.4 million in 2021, then soared by 120.82% to $20.7 million in 2022, then dropped by 25.25% to $15.5 million in 2023, then sank by 81.69% to $2.8 million in 2024, then slumped by 76.58% to $663000.0 in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $663000.0, $990000.0, and $2.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | 663,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 663,000.00 |
| Jun 30, 2025 | 990,000.00 |
| Dec 31, 2024 | 2.83 Mn |
| Jun 30, 2024 | 6.16 Mn |
| Dec 31, 2023 | 15.46 Mn |
| Jun 30, 2023 | 16.00 Mn |
| Dec 31, 2022 | 20.69 Mn |
| Dec 31, 2021 | -99.37 Mn |